RIVENDELL GROUP LLP for GENENTECH
What was lobbied
6 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Concerns regarding Medicare policies for Part B drugs; 21st Century Cures Initiative; issues concerning implementation of Patient Protection and Affordable Care Act; Drug Pricing under 340B program
| Lobbyist | Covered position, as disclosed |
|---|---|
| MATTHEW LAWRENCE BERZOK New | LD and Chief Counsel, Rep. Bart Stupak, LA Rep. Peter Deutsch |
| NICK KOLOVOS New | LA and Counsel, Rep. Anna Eshoo |
Taxation/Internal Revenue Code TAX
Concerns regarding Medicare policies for Part B drugs; 21st Century Cures Initiative; issues concerning implementation of Patient Protection and Affordable Care Act; Drug Pricing under 340B program
| Lobbyist | Covered position, as disclosed |
|---|---|
| MATTHEW LAWRENCE BERZOK New | LD and Chief Counsel, Rep. Bart Stupak, LA Rep. Peter Deutsch |
| NICK KOLOVOS New | LA and Counsel, Rep. Anna Eshoo |
Copyright/Patent/Trademark CPT
Concerns regarding Medicare policies for Part B drugs; 21st Century Cures Initiative; issues concerning implementation of Patient Protection and Affordable Care Act; Drug Pricing under 340B program
| Lobbyist | Covered position, as disclosed |
|---|---|
| MATTHEW LAWRENCE BERZOK New | LD and Chief Counsel, Rep. Bart Stupak, LA Rep. Peter Deutsch |
| NICK KOLOVOS New | LA and Counsel, Rep. Anna Eshoo |
Medicare/Medicaid MMM
Concerns regarding Medicare policies for Part B drugs; 21st Century Cures Initiative; issues concerning implementation of Patient Protection and Affordable Care Act; Drug Pricing under 340B program
| Lobbyist | Covered position, as disclosed |
|---|---|
| MATTHEW LAWRENCE BERZOK New | LD and Chief Counsel, Rep. Bart Stupak, LA Rep. Peter Deutsch |
| NICK KOLOVOS New | LA and Counsel, Rep. Anna Eshoo |
Budget/Appropriations BUD
Concerns regarding Medicare policies for Part B drugs; 21st Century Cures Initiative; issues concerning implementation of Patient Protection and Affordable Care Act; Drug Pricing under 340B program
| Lobbyist | Covered position, as disclosed |
|---|---|
| MATTHEW LAWRENCE BERZOK New | LD and Chief Counsel, Rep. Bart Stupak, LA Rep. Peter Deutsch |
| NICK KOLOVOS New | LA and Counsel, Rep. Anna Eshoo |
Trade (domestic/foreign) TRD
Concerns regarding Medicare policies for Part B drugs; 21st Century Cures Initiative; issues concerning implementation of Patient Protection and Affordable Care Act; Drug Pricing under 340B program
| Lobbyist | Covered position, as disclosed |
|---|---|
| MATTHEW LAWRENCE BERZOK New | LD and Chief Counsel, Rep. Bart Stupak, LA Rep. Peter Deutsch |
| NICK KOLOVOS New | LA and Counsel, Rep. Anna Eshoo |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.